Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Filip van den Bosch

Showing results (71-80 of 193) with videos related to

Pageof 20
Sort By:
Arthritis and Rheumatism|July 29, 2006
Infliximab improves productivity and reduces workday loss in patients with ankylosing spondylitis: results from a randomized, placebo-controlled trialDésirée van der Heijde, Chenglong Han, Kirt DeVlam, et al.
RMD Open|February 9, 2017
Efficacy and safety of non-pharmacological and non-biological pharmacological treatment: a systematic literature review informing the 2016 update of the ASAS/EULAR recommendations for the management of axial spondyloarthritisAndrea Regel, Alexandre Sepriano, Xenofon Baraliakos, et al.
RMD Open|March 14, 2018
Long-term efficacy and predictors of remission following adalimumab treatment in peripheral spondyloarthritis: 3-year results from ABILITY-2Filip Van den Bosch, Philip J Mease, Joachim Sieper, et al.
Annals of the Rheumatic Diseases|March 3, 2018
Dual-energy CT: a new imaging modality for bone marrow oedema in rheumatoid arthritisLennart Jans, Isabelle De Kock, Nele Herregods, et al.
Rheumatology (Oxford, England)|September 20, 2014
Characteristics associated with the presence and development of extra-articular manifestations in ankylosing spondylitis: 12-year results from OASISIvette Essers, Sofia Ramiro, Carmen Stolwijk, et al.
EJNMMI Research|December 14, 2016
<sup>99m</sup>Tc-labelled S-HYNIC certolizumab pegol in rheumatoid arthritis and spondyloarthritis patients: a biodistribution and dosimetry studyBieke Lambert, Philippe Carron, Yves D'Asseler, et al.
RMD Open|August 29, 2024
Exploratory analysis of the potential disconnect between objective inflammatory response and clinical response following certolizumab pegol treatment in patients with active axial spondyloarthritisMartin Rudwaleit, Helena Marzo-Ortega, Victoria Navarro-Compán, et al.
Clinical and Experimental Rheumatology|February 5, 2016
Do extra-articular manifestations influence outcome in ankylosing spondylitis? 12-year results from OASISIvette Essers, Sofia Ramiro, Carmen Stolwijk, et al.
Radiology|December 22, 2020
MRI-based Synthetic CT in the Detection of Structural Lesions in Patients with Suspected Sacroiliitis: Comparison with MRILennart B O Jans, Min Chen, Dirk Elewaut, et al.
Rheumatology (Oxford, England)|December 5, 2021
Cluster analysis in early axial spondyloarthritis predicts poor outcome in the presence of peripheral articular manifestationsFélicie Costantino, Philippe Aegerter, Georg Schett, et al.
Pageof 20

Showing results (71-80 of 193) with videos related to

Sort By:
Pageof 20
Arthritis and Rheumatism|July 29, 2006
Infliximab improves productivity and reduces workday loss in patients with ankylosing spondylitis: results from a randomized, placebo-controlled trialDésirée van der Heijde, Chenglong Han, Kirt DeVlam, et al.
RMD Open|February 9, 2017
Efficacy and safety of non-pharmacological and non-biological pharmacological treatment: a systematic literature review informing the 2016 update of the ASAS/EULAR recommendations for the management of axial spondyloarthritisAndrea Regel, Alexandre Sepriano, Xenofon Baraliakos, et al.
RMD Open|March 14, 2018
Long-term efficacy and predictors of remission following adalimumab treatment in peripheral spondyloarthritis: 3-year results from ABILITY-2Filip Van den Bosch, Philip J Mease, Joachim Sieper, et al.
Annals of the Rheumatic Diseases|March 3, 2018
Dual-energy CT: a new imaging modality for bone marrow oedema in rheumatoid arthritisLennart Jans, Isabelle De Kock, Nele Herregods, et al.
Rheumatology (Oxford, England)|September 20, 2014
Characteristics associated with the presence and development of extra-articular manifestations in ankylosing spondylitis: 12-year results from OASISIvette Essers, Sofia Ramiro, Carmen Stolwijk, et al.
EJNMMI Research|December 14, 2016
<sup>99m</sup>Tc-labelled S-HYNIC certolizumab pegol in rheumatoid arthritis and spondyloarthritis patients: a biodistribution and dosimetry studyBieke Lambert, Philippe Carron, Yves D'Asseler, et al.
RMD Open|August 29, 2024
Exploratory analysis of the potential disconnect between objective inflammatory response and clinical response following certolizumab pegol treatment in patients with active axial spondyloarthritisMartin Rudwaleit, Helena Marzo-Ortega, Victoria Navarro-Compán, et al.
Clinical and Experimental Rheumatology|February 5, 2016
Do extra-articular manifestations influence outcome in ankylosing spondylitis? 12-year results from OASISIvette Essers, Sofia Ramiro, Carmen Stolwijk, et al.
Radiology|December 22, 2020
MRI-based Synthetic CT in the Detection of Structural Lesions in Patients with Suspected Sacroiliitis: Comparison with MRILennart B O Jans, Min Chen, Dirk Elewaut, et al.
Rheumatology (Oxford, England)|December 5, 2021
Cluster analysis in early axial spondyloarthritis predicts poor outcome in the presence of peripheral articular manifestationsFélicie Costantino, Philippe Aegerter, Georg Schett, et al.
Pageof 20